Home/Answers/Why does perimenopause cause acne?
Hormones & biology

Why does perimenopause cause acne?

By Jennifer Candela · July 30, 2026

This is one of the most common questions I get, and it makes women feel a little crazy — you're forty-two, you're going through what everyone told you would be hot flashes and mood changes, and instead you have teenage acne on your chin and nobody warned you.

Here's what's actually happening.

In perimenopause, estrogen production from your ovaries starts to become erratic and, over time, decline. Your androgens — testosterone and DHEA-S — don't decline nearly as fast. So the ratio between them shifts. You have less estrogen relative to the same amount of testosterone.

Estrogen has been quietly keeping sebum production in check for you your whole adult life. When that estrogen protection weakens, the androgens you always had become more visible — biologically. More oil. More clogged follicles. More inflammatory breakouts. Almost always along the jawline and chin, because that's where the androgen-sensitive sebaceous glands are densest.

This is often paired with two other changes women notice at the same time and don't always connect. First, dryness — because estrogen was also supporting barrier function, and losing it affects both moisture retention and inflammation. Yes, you can have oily acne skin and dry skin at the same time in perimenopause. Second, more visible pores and looser skin around the jaw, because the same estrogen decline is reducing collagen synthesis.

What actually helps:

The JenSkin panel measures estradiol and fasting insulin as part of the standard nine, so you can see the pattern rather than guess at it.

—   Go deeper   —
Hormones, skin, and the seasons of a woman's life →

Did this answer your question?

References

  1. Zeichner JA et al. "Emerging issues in adult female acne." Journal of Clinical & Aesthetic Dermatology, 2017;10(1):37-46.
  2. Rzepecki AK et al. "Estrogen, hormonal replacement therapy and its regulation on the skin." International Journal of Women's Dermatology, 2019;5(2):85-90.
  3. NAMS Advisory Panel. "The 2022 Hormone Therapy Position Statement of NAMS." Menopause, 2022;29(7):767-794.